Federal Register: FDA Issues Notice, Termination, Reestablishment of Federal Advisory Committee for Peripheral and Central Nervous System Drugs Advisory Committee
July 23, 2026
July 23, 2026
WASHINGTON, July 23 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
The Food and Drug Administration (FDA) is announcing the termination and reestablishment of the Peripheral and Central Nervous System Drugs Advisory Committee by the Commissioner of Food and Drugs. The Peripheral and Central Nervous System Drugs Advisory Committee was terminated on June 4, 2026, because i . . .
* * *
The Food and Drug Administration (FDA) is announcing the termination and reestablishment of the Peripheral and Central Nervous System Drugs Advisory Committee by the Commissioner of Food and Drugs. The Peripheral and Central Nervous System Drugs Advisory Committee was terminated on June 4, 2026, because i . . .